688016 心脉医疗
已收盘 04-19 15:00:00
资讯
新帖
简况
心脉医疗获融资买入0.13亿元,近三日累计买入0.27亿元
金融界 · 04-18 08:24
心脉医疗获融资买入0.13亿元,近三日累计买入0.27亿元
心脉医疗04月17日获主力加仓2198万元 环比增加2580.49%
自选股智能写手 · 04-17 15:18
心脉医疗04月17日获主力加仓2198万元 环比增加2580.49%
北向资金4月15日净买入心脉医疗3.73万股 连续3日增持
自选股智能写手 · 04-16
北向资金4月15日净买入心脉医疗3.73万股 连续3日增持
手机厂生产汽车?如何理解“跨次元”制造?
银华基金 · 04-16
手机厂生产汽车?如何理解“跨次元”制造?
北向资金4月10日净卖出心脉医疗2.57万股 连续5日减持
自选股智能写手 · 04-11
北向资金4月10日净卖出心脉医疗2.57万股 连续5日减持
心脉医疗04月10日主力资金流入45万元 连续3日加仓
自选股智能写手 · 04-10
心脉医疗04月10日主力资金流入45万元 连续3日加仓
财信证券给予心脉医疗买入评级 业绩稳健增长 新品研发不断推进
每日经济新闻 · 04-09
财信证券给予心脉医疗买入评级 业绩稳健增长 新品研发不断推进
科创新动能助力经济回暖,中小盘成长赛道很有看头!
鹏华基金 · 04-09
科创新动能助力经济回暖,中小盘成长赛道很有看头!
心脉医疗(688016)业绩稳健兑现,外周产品有望不断获批
中金公司 · 04-01
心脉医疗(688016)业绩稳健兑现,外周产品有望不断获批
技术迭代热点频出,我们能否一基布局?
银华基金 · 04-01
技术迭代热点频出,我们能否一基布局?
心脉医疗(688016)2023年业绩点评:23年业绩快速增长 研发投入持续强劲
光大证券股份有... · 03-28
心脉医疗(688016)2023年业绩点评:23年业绩快速增长 研发投入持续强劲
平安证券:给予心脉医疗增持评级
证券之星 · 03-28
平安证券:给予心脉医疗增持评级
心脉医疗(688016)2月29日股东户数1.01万户,较上期增加3.12%
证券之星 · 03-28
心脉医疗(688016)2月29日股东户数1.01万户,较上期增加3.12%
心脉医疗大幅上涨 发布2023年年度报告
智选洞察 · 03-28
心脉医疗大幅上涨 发布2023年年度报告
社保基金去年四季度持有科创板股名单(附股)
证券时报网 · 03-28
社保基金去年四季度持有科创板股名单(附股)
图解心脉医疗年报:第四季度单季净利润同比增85.74%
证券之星 · 03-28
图解心脉医疗年报:第四季度单季净利润同比增85.74%
心脉医疗2023年净利4.92亿同比增长37.98% 财务总监李春芳薪酬120.71万
挖贝网 · 03-27
心脉医疗2023年净利4.92亿同比增长37.98% 财务总监李春芳薪酬120.71万
注意!心脉医疗将于4月18日召开股东大会
每日经济新闻 · 03-27
注意!心脉医疗将于4月18日召开股东大会
心脉医疗将于4月18日召开股东大会,审议续聘会计师事务所等议案
金融界 · 03-27
心脉医疗将于4月18日召开股东大会,审议续聘会计师事务所等议案
加载更多
公司概况
公司名称:
上海微创心脉医疗科技(集团)股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-07-22
主营业务:
上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。
发行价格:
46.23
{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":170.39,"timestamp":1713510000000,"preClose":170.67,"halted":0,"volume":474249,"delay":0,"floatShares":71978100,"shares":82726299,"eps":7.5912,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.28,"latestTime":"04-19 15:00:00","open":169.22,"high":171.86,"low":168.45,"amount":80728700,"amplitude":0.02,"askPrice":170.39,"askSize":3,"bidPrice":170.36,"bidSize":7,"shortable":0,"etf":0,"ttmEps":7.5912,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"adjPreClose":170.67,"symbolType":"stock_kcb","openAndCloseTimeList":[[1713490200000,1713497400000],[1713502800000,1713510000000]],"highLimit":187.74,"lowLimit":153.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":82726253,"pbRate":3.67,"roa":"--","roe":"26.43%","epsLYR":6.81,"committee":0.317073,"marketValue":14096000000,"floatMarketCap":12264000000,"peRate":22.445727,"changeRate":-0.0016,"turnoverRate":0.0066,"status":1,"afterMarket":{"amount":0,"volume":0,"close":170.39,"buyVolume":0,"sellVolume":0,"time":1713512039960,"indexStatus":"已收盘 04-19 15:30:00","preClose":170.67}},"requestUrl":"/m/hq/s/688016","defaultTab":"news","newsList":[{"id":"2428301551","title":"心脉医疗获融资买入0.13亿元,近三日累计买入0.27亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428301551","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2428301551?lang=zh_cn&edition=full","pubTime":"2024-04-18 08:24","pubTimestamp":1713399877,"startTime":"0","endTime":"0","summary":"4月17日,沪深两融数据显示,心脉医疗获融资买入额0.13亿元,居两市第601位,当日融资偿还额0.10亿元,净买入256.02万元。最近三个交易日,15日-17日,心脉医疗分别获融资买入0.06亿元、0.08亿元、0.13亿元。融券方面,当日融券卖出0.19万股,净买入0.52万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418082456878c3b55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418082456878c3b55&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428625113","title":"心脉医疗04月17日获主力加仓2198万元 环比增加2580.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428625113","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428625113?lang=zh_cn&edition=full","pubTime":"2024-04-17 15:18","pubTimestamp":1713338307,"startTime":"0","endTime":"0","summary":"04月17日, 心脉医疗股价涨0.87%,报收171.13元,成交金额1.46亿元,换手率1.19%,振幅3.22%,量比1.27。心脉医疗今日主力资金净流入2198万元,连续3日净流入,上一交易日主力净流入82万元,今日环比增加2580.49%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为40.00%,平均涨幅为1.88%。该股近5个交易日下跌4.59%,主力资金累计净流出495万元;近20日主力资金累计净流出623万元,其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171526008b2dc9c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171526008b2dc9c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427586864","title":"北向资金4月15日净买入心脉医疗3.73万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427586864","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427586864?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:30","pubTimestamp":1713231034,"startTime":"0","endTime":"0","summary":"4月15日, 北向资金增持心脉医疗3.73万股,连续3日增持。截止当日收盘,沪股通共持有心脉医疗68.74万股,占流通股0.95%。沪股通增持金额前五个股分别为贵州茅台、中国建筑、山西汾酒、兴业银行、招商银行。心脉医疗近5个交易日下跌2.90%,沪股通累计增持3.24万股;近20个交易日下跌4.77%,沪股通累计减持2.32万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160934468781ded8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160934468781ded8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427855934","title":"手机厂生产汽车?如何理解“跨次元”制造?","url":"https://stock-news.laohu8.com/highlight/detail?id=2427855934","media":"银华基金","top":-1,"share":"https://www.laohu8.com/m/news/2427855934?lang=zh_cn&edition=full","pubTime":"2024-04-16 07:44","pubTimestamp":1713224651,"startTime":"0","endTime":"0","summary":"一家以智能手机和智能家居产品闻名的科技企业,其进军汽车行业的消息一经发布,便引起了市场的广泛关注和热议。产业融合下,“跨次元”的企业生产出的产品具有创新性、多样性和高度集成的优势。通过高新技术的深度整合,“跨次元”企业能够快速响应市场变化,满足消费者对于个性化和智能化的需求。六、以上基金由银华基金依照有关法律法规及约定申请募集,并经中国证券监督管理委员会许可注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041607421687e808af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041607421687e808af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426710964","title":"北向资金4月10日净卖出心脉医疗2.57万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2426710964","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426710964?lang=zh_cn&edition=full","pubTime":"2024-04-11 09:30","pubTimestamp":1712799035,"startTime":"0","endTime":"0","summary":"4月10日,北向资金减持心脉医疗2.57万股连续5日减持。截止当日收盘,沪股通共持有心脉医疗62.01万股,占流通股0.86%。沪股通减持金额前五个股分别为中国中免、贵州茅台、斯达半导、澜起科技、恒立液压。心脉医疗近5个交易日下跌4.61%,沪股通累计减持11.74万股;近20个交易日下跌3.75%,沪股通累计减持10.52万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110934498b0d6235&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110934498b0d6235&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426453835","title":"心脉医疗04月10日主力资金流入45万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426453835","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426453835?lang=zh_cn&edition=full","pubTime":"2024-04-10 15:18","pubTimestamp":1712733525,"startTime":"0","endTime":"0","summary":"04月10日, 心脉医疗股价跌1.17%,报收179.37元,成交金额6677万元,换手率0.52%,振幅1.98%,量比0.65。心脉医疗今日主力资金净流入45万元,连续3日净流入,上一交易日主力净流入96万元,今日环比减少53.12%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为44.44%,平均涨幅为1.88%。该股近5个交易日下跌4.61%,主力资金累计净流入545万元;近20日主力资金累计净流入1177万元,其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410153425875f244f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410153425875f244f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426306651","title":"财信证券给予心脉医疗买入评级 业绩稳健增长 新品研发不断推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2426306651","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2426306651?lang=zh_cn&edition=full","pubTime":"2024-04-09 15:11","pubTimestamp":1712646660,"startTime":"0","endTime":"0","summary":"财信证券04月09日发布研报称,给予心脉医疗(688016.SH,最新价:181.5元)买入评级。评级理由主要包括:1)主动脉支架实现稳健增长,术中支架和外周产品快速放量;2)创新研发投入加码,积极推进多款产品上市;3)全球化发展加速推进,海外市场覆盖率不断提升。风险提示:集采降价风险,产品研发上市进度不及预期,产品销售推广不及预期等。AI点评:心脉医疗近一个月获得6份券商研报关注,买入4家,增持1家。文章来源:每日经济新闻原标题:财信证券给予心脉医疗买入评级,业绩稳健增长,新品研发不断推进","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091519128b022aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091519128b022aaa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426972323","title":"科创新动能助力经济回暖,中小盘成长赛道很有看头!","url":"https://stock-news.laohu8.com/highlight/detail?id=2426972323","media":"鹏华基金","top":-1,"share":"https://www.laohu8.com/m/news/2426972323?lang=zh_cn&edition=full","pubTime":"2024-04-09 07:54","pubTimestamp":1712620476,"startTime":"0","endTime":"0","summary":"但我国3月份制造业和非制造业的PMI指数都稳稳地站在了荣枯线之上,预示着经济继续回暖的良好前景。这样看来,科创新动能正逐渐替代传统产业成为我国经济增长新引擎,叠加全球科技创新浪潮推动,成长赛道投资逻辑依旧坚挺。而科创100指数以其独特的中小盘特性、鲜明的成长预期以及“硬科技”属性,无论是在短期还是中长期,都展现出了巨大的投资潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409075109861e3ff3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409075109861e3ff3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424764188","title":"心脉医疗(688016)业绩稳健兑现,外周产品有望不断获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2424764188","media":"中金公司","top":-1,"share":"https://www.laohu8.com/m/news/2424764188?lang=zh_cn&edition=full","pubTime":"2024-04-01 16:23","pubTimestamp":1711959825,"startTime":"0","endTime":"0","summary":"截至2023年底,公司产品已覆盖国内2,100家主要医院,核心产品Castor胸主分支支架/Minos腹主支架和PTX外周药球分别覆盖超过1,000/800/900家医院。截至1Q24,暂无主动脉支架多省联盟以上级别的集采出现。创新产品有望步入收获期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404011641088ae3557e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404011641088ae3557e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424732668","title":"技术迭代热点频出,我们能否一基布局?","url":"https://stock-news.laohu8.com/highlight/detail?id=2424732668","media":"银华基金","top":-1,"share":"https://www.laohu8.com/m/news/2424732668?lang=zh_cn&edition=full","pubTime":"2024-04-01 11:31","pubTimestamp":1711942267,"startTime":"0","endTime":"0","summary":"产业面,AI技术在医疗领域的应用已经涵盖了智能诊断、医疗影像分析、疾病预测与防控、个性化医疗、药物研发和健康管理等多个方面。在AI制药领域,AI技术的应用已经能够帮助缩减新药开发的时间和成本。政策面,从医院评级、智慧管理到AI医疗器械管制,相关政策不断出台,为AI技术在医疗领域的应用提供了明确的发展方向和规范。整体来说,AI+医疗政策面和产业面有望形成共振,促进AI技术迭代对医药创新赛道的持续赋能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404011127537a50598a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404011127537a50598a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422082162","title":"心脉医疗(688016)2023年业绩点评:23年业绩快速增长 研发投入持续强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2422082162","media":"光大证券股份有...","top":-1,"share":"https://www.laohu8.com/m/news/2422082162?lang=zh_cn&edition=full","pubTime":"2024-03-28 19:43","pubTimestamp":1711626215,"startTime":"0","endTime":"0","summary":"事件:公司发布23 年年报,2023 年全年实现收入11.87 亿元,归母净利润4.92 亿元,扣非归母净利润4.62 亿元。单季度来看,23 年Q4 单季度实现收入2.99 亿元,归母净利润1.04 亿元,业绩符合市场预期。分产品来看,公司主动脉支架收入9.40 亿元,术中支架收入1.32 亿元,外周及其他收入1.15 亿元。研发持续强劲,产品管线有望进一步丰富。2023 年公司各研发管线均取得重要进展,6 款产品向国家药监局递交注册资料。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281943428b6da39b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281943428b6da39b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422686211","title":"平安证券:给予心脉医疗增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2422686211","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422686211?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:17","pubTimestamp":1711621025,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,倪亦道近期对心脉医疗进行研究并发布了研究报告《2023高增长兑现,产品渗透与迭代保障增长持续性》,本报告对心脉医疗给出增持评级,当前股价为181.61元。海外毛利率因传统OEM产品收入占比进一步下降,毛利率同比增加5.95pct。维持“推荐”评级。最新盈利预测明细如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为213.9。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281818308b6d5ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281818308b6d5ef4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422515401","title":"心脉医疗(688016)2月29日股东户数1.01万户,较上期增加3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422515401","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422515401?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:13","pubTimestamp":1711617210,"startTime":"0","endTime":"0","summary":"证券之星消息,近日心脉医疗披露,截至2024年2月29日公司股东户数为1.01万户,较12月31日增加306.0户,增幅为3.12%。在医疗器械行业个股中,心脉医疗股东户数低于行业平均水平,截至2月29日,医疗器械行业平均股东户数为2.18万户。心脉医疗近1年股东户数变动明细见下表:根据统计,心脉医疗2023年12月31日至2024年2月29日,主力资金净流出5767.19万元,游资资金净流入1.1亿元,散户资金净流出5260.26万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032817162587bffb75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032817162587bffb75&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422907002","title":"心脉医疗大幅上涨 发布2023年年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2422907002","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2422907002?lang=zh_cn&edition=full","pubTime":"2024-03-28 10:00","pubTimestamp":1711591249,"startTime":"0","endTime":"0","summary":"03月28日,心脉医疗股价大幅上涨,截至10点00分,心脉医疗上涨5.13%,报183.50元/股,成交9385万元,换手率0.72%,振幅4.18%。消息解读心脉医疗发布2023年年度报告,报告期内公司实现营业收入11.87亿元,同比增长32.43%;归属于上市公司股东的净利润4.92亿元,同比增长37.98%;归属于上市公司股东的扣除非经常性损益的净利润4.62亿元,同比增长42.74%;基本每股收益6.81元/股。现通报第五批医疗器械网络销售违法违规案件信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328105322791d6ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328105322791d6ab0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422974274","title":"社保基金去年四季度持有科创板股名单(附股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2422974274","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2422974274?lang=zh_cn&edition=full","pubTime":"2024-03-28 08:14","pubTimestamp":1711584840,"startTime":"0","endTime":"0","summary":"证券时报网讯,证券时报数据宝统计显示,社保基金最新出现在12只科创板股前十大流通股东名单中,合计持股量7450.04万股,期末持股市值合计38.42亿元。社保基金持有科创板股中,从前十大流通股东名单中社保基金家数来看,生益电子、奥特维、心脉医疗等3只股有2家社保基金集中现身,持股量分别为1565.61万股、497.44万股、330.34万股。社保基金持股市值居前的有柏楚电子、心脉医疗、联瑞新材,持股市值分别为8.74亿元、6.43亿元、4.72亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280826138b6b6a0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280826138b6b6a0f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422949269","title":"图解心脉医疗年报:第四季度单季净利润同比增85.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422949269","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422949269?lang=zh_cn&edition=full","pubTime":"2024-03-28 01:36","pubTimestamp":1711560996,"startTime":"0","endTime":"0","summary":"证券之星消息,心脉医疗2023年年报显示,公司主营收入11.87亿元,同比上升32.43%;归母净利润4.92亿元,同比上升37.98%;扣非净利润4.62亿元,同比上升42.74%;其中2023年第四季度,公司单季度主营收入2.99亿元,同比上升28.63%;单季度归母净利润1.04亿元,同比上升85.74%;单季度扣非净利润9687.27万元,同比上升100.91%;负债率9.01%,投资收益914.85万元,财务费用-841.38万元,毛利率76.45%。财报数据概要请见下图:以上内容由证券之星根据公开信息整理,由算法生成,与本站立场无关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280140288b6a7b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280140288b6a7b18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422156539","title":"心脉医疗2023年净利4.92亿同比增长37.98% 财务总监李春芳薪酬120.71万","url":"https://stock-news.laohu8.com/highlight/detail?id=2422156539","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2422156539?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:26","pubTimestamp":1711549601,"startTime":"0","endTime":"0","summary":"报告期内经营活动产生的现金流量净额为558,305,913.27元,归属于上市公司股东的净资产3,843,816,151.24元。报告期内公司实现营业收入1,187,204,459.56元,同比增长32.43%;归属于上市公司股东的净利润492,431,974.71元,同比增长37.98%。本报告期内营业收入、归属于上市公司股东的净利润增长均超30%,主要系报告期内公司主要产品受到市场广泛认可,产品竞争力持续增强,产销量稳步提升。公告显示,报告期内董事、监事、高级管理人员报酬合计1,594.02万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272230588b69ffe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272230588b69ffe2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422399573","title":"注意!心脉医疗将于4月18日召开股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2422399573","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2422399573?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:46","pubTimestamp":1711539965,"startTime":"0","endTime":"0","summary":"心脉医疗3月27日发布公告称,2024年4月18日13点30分,公司将在上海市浦东新区康新公路3399弄25号楼9层公司会议室召开2023年年度股东大会。本次股东大会将审议《公司2023年年度报告及其摘要》等议案,2024年4月11日收市后登记在册的股东可现场参会投票,或通过交易所投票系统行使表决权。2022年1至12月份,心脉医疗的营业收入构成为:主动脉及外周血管用产品占比100.0%。截至发稿,心脉医疗市值为144亿元。心脉医疗将于4月18日召开股东大会","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032719591987bc3972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032719591987bc3972&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422222960","title":"心脉医疗将于4月18日召开股东大会,审议续聘会计师事务所等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2422222960","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422222960?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:44","pubTimestamp":1711539855,"startTime":"0","endTime":"0","summary":"金融界3月27日消息,心脉医疗发布公告,将于2024年4月18日召开年度股东大会,网络投票同日进行。股权登记日为4月11日,当日收市后持有心脉医疗股票的投资者可以参与投票。会议地点:上海市浦东新区康新公路3399弄25号楼9层公司会议室。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032719441787bc2f0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032719441787bc2f0d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","stockEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":-0.0761},{"period":"3month","weight":-0.03},{"period":"6month","weight":-0.0794},{"period":"1year","weight":-0.0777},{"period":"ytd","weight":-0.1231}],"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","perCapita":"7112股","boardName":"专用设备制造业","registeredCapital":"8272万元","compareEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":0.0037},{"period":"3month","weight":0.0854},{"period":"6month","weight":0.0306},{"period":"1year","weight":-0.0878},{"period":"ytd","weight":0.0334}],"survey":" 上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。","serverTime":1713534989802,"listedPrice":46.23,"stockholders":"10120人(较上一季度增加3.12%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}